Article Text

PDF

Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences
  1. Maarten de Wit1,
  2. Tineke Abma1,
  3. Marije Koelewijn-van Loon2,
  4. Sarah Collins3,
  5. John Kirwan4
  1. 1Metamedica, VU Medical Centre, Amsterdam, The Netherlands
  2. 2Department of General Practice, Maastricht University Medical Centre, Maastricht, The Netherlands
  3. 3Patient Research Partner, Surrey, UK
  4. 4Department of Rheumatology, University of Bristol, Rheumatology Unit Bristol Royal Infirmary, Bristol, UK
  1. Correspondence to Maarten Wit; mp.dewit{at}vumc.nl

Abstract

Objective To assess the inclusion of patients as international research partners in Outcome Measures in Rheumatology (OMERACT) conferences and how this has influenced the scope and conduct of outcomes research in rheumatology.

Design A thematic content analysis of OMERACT internal documents, publications and conference proceedings, followed by a responsive evaluation including 32 qualitative semistructured interviews.

Setting The international, biannual research conference OMERACT 10 (Malaysia, 2010).

Participants Senior researchers (n=10), junior researchers (n=2), representatives of the pharmaceutical industry and regulators (n=2), conference staff (n=2), new patient delegates (n=8) and experienced patient delegates (n=8).

Results The role of patients evolved over 10 years from a single patient focus group to full participation in all areas of the meeting and inclusion in research group meetings between conferences. Five main categories of impact emerged: widening the research agenda; including patient relevant outcomes in core sets; enhancing patient reported instruments; changing the culture of OMERACT and consequences outside OMERACT. Patient participants identified previously neglected outcome domains such as fatigue, sleep disturbances and flares which prompted collaborative working on new programmes of research. Specific benefits and challenges for patients and professionals were identified, such as personal fulfilment, widening of research interests, difficulties in establishing equal partnerships and concerns about loss of research rigour.

Conclusions Including patients as partners in OMERACT conferences has widened its focus and adjusted the way of working. It has resulted in new developments in the research agenda and the use of more patient-relevant outcomes in clinical trials. These collaborations have influenced perceptions and beliefs among many patients and researchers, and led to wider patient involvement as partners in research.

  • Health impact assessment
  • Qualitative research
  • Rheumatology

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.